SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001739410-24-000105
Filing Date
2024-07-23
Accepted
2024-07-23 16:06:38
Documents
14
Period of Report
2024-07-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rlyb-20240723.htm   iXBRL 8-K 29648
2 EX-10.1 rlyb-2024723xex101.htm EX-10.1 39489
  Complete submission text file 0001739410-24-000105.txt   208293

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20240723.xsd EX-101.SCH 1892
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20240723_lab.xml EX-101.LAB 23449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20240723_pre.xml EX-101.PRE 13575
16 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20240723_htm.xml XML 2917
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

IRS No.: 851083789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40693 | Film No.: 241134522
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)